AltStreet
EDGAR Verified
Primary Source · SEC.gov

AVSF - Precision Neuroscience 2022, LLC

Fund Vehicle2023 vintageRule 506(b), Section 3(c), Section 3(c)(1)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Raised

$2M

Investors

193

Min Invest

$5,000

What this filing shows

·

Every sentence is a value as filed on SEC Form D

AVSF - Precision Neuroscience 2022, LLC is a Delaware limited liability company that filed a Form D with the SEC on January 20, 2023, describing itself as a venture capital fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(1) and covers equity and pooled investment fund interests. AVSF - Precision Neuroscience 2022, LLC reported $2,303,347 sold from 193 investors of a $2,303,347 total offering as of the Form D filed January 20, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $5,000. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. The issuer's address of record is 670 North Commercial Street, Suite 403, Manchester, NH 03101.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001962853
Entity NameAVSF - Precision Neuroscience 2022, LLC
ExemptionRule 506(b), Section 3(c), Section 3(c)(1)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(1) of the Investment Company Act: the fund is excluded from investment-company registration because it has no more than 100 beneficial owners.
Entity TypeLimited Liability Company
Jurisdiction of OrganizationDelaware
Issuer Address670 North Commercial Street, Suite 403, Manchester, NH 03101
Phone(603) 518-8112
Industry / Fund TypePooled Investment Fund · Venture Capital Fund
Investment Company ActExcluded under Section 3(c)(1) (100 beneficial owners or fewer)
Securities TypeEquity, Pooled investment fund interests
First Sale DateJanuary 6, 2023
Filing DateJanuary 20, 2023
Accession Number0001962853-23-000001
Total Offering Amount$2,303,347
Total Amount Sold$2,303,347
Amount Remaining$0
Total Investors193
Non-Accredited InvestorsNone
Minimum Investment$5,000
Offering DurationOne year or less
Revenue Range$1 - $1,000,000
State (Issuer Address)MA
Amendment CountOriginal filing only

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

DJanuary 20, 2023

Fund Family

Every vehicle in this manager's series as it appears on EDGAR, newest generation first. Sold-to-date and investor counts are each vehicle's latest Form D.

Fund family

AVSF Precision Neuroscience3 vehicles · 0 generations · since 2023 · $4.5M sold across the family

VehicleRoleFirst filedStatusSoldInvestors
Unnumbered · first filed 2023-01-20 · 3 vehicles · $4.5M sold · 323 investors
AVSF - Precision Neuroscience 2022, LLCthis issuer2023-01-20closed$2.3M193
AVSF - Precision Neuroscience 2024, LLC2024-10-21closed$1.1M72
AVSF - Precision Neuroscience 2026, LLC2026-10-13raising$1.0M58

Grouped from Form D issuer names (generation, sleeve, jurisdiction and legal-form tokens removed); a name-only match, so abbreviated or renamed vehicles can be missed. Sold and investor figures are each vehicle's latest Form D; sleeves that report the same figure share one family-wide total and are counted once. Performance lines are what a public pension plan reports for its own interest in that fund, net, on the plan's cash flows and valuation date; they are not the general partner's figures.

In the Terminal

Filing events

0

none on file

Critical / warning

0 / 0

0 watch · 0 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

closed

Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Michael Collins

Executive Officer · Manchester, NH

CEO of Alumni Ventures Group, the Issuers Sole Manager

Questions About AVSF - Precision Neuroscience 2022, LLC

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is AVSF - Precision Neuroscience 2022, LLC?

AVSF - Precision Neuroscience 2022, LLC is a Delaware limited liability company that filed a Form D with the SEC on January 20, 2023 as a venture capital fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of equity and pooled investment fund interests.

Is AVSF - Precision Neuroscience 2022, LLC legit?

AltStreet does not rate legitimacy; it reports the public record. AVSF - Precision Neuroscience 2022, LLC filed a Form D with the SEC on January 20, 2023 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $2,303,347 sold to 193 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is AVSF - Precision Neuroscience 2022, LLC registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that AVSF - Precision Neuroscience 2022, LLC claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has AVSF - Precision Neuroscience 2022, LLC raised?

AVSF - Precision Neuroscience 2022, LLC reported $2,303,347 sold from 193 investors of a $2,303,347 total offering as of the Form D filed January 20, 2023.

Who can invest in AVSF - Precision Neuroscience 2022, LLC?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $5,000.

What is the minimum investment in AVSF - Precision Neuroscience 2022, LLC?

The Form D lists $5,000 as the minimum investment accepted from any outside investor as of January 20, 2023. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling AVSF - Precision Neuroscience 2022, LLC and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.

Who is behind AVSF - Precision Neuroscience 2022, LLC?

The Form D lists 1 related person: Michael Collins, executive officer (CEO of Alumni Ventures Group, the Issuers Sole Manager). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is AVSF - Precision Neuroscience 2022, LLC located?

The issuer's address on its SEC filings is 670 North Commercial Street, Suite 403, Manchester, NH 03101. Its phone number of record is 603-518-8112. It is organized under the laws of Delaware.

How long is the AVSF - Precision Neuroscience 2022, LLC offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

How large is AVSF - Precision Neuroscience 2022, LLC?

The Form D reports a revenue range of $1 - $1,000,000.

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.